Detalles de la búsqueda
1.
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
N Engl J Med
; 385(1): 46-58, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34192431
2.
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.
Biol Blood Marrow Transplant
; 22(10): 1801-1807, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27377900
3.
The six-minute walk test is a valuable measure of functional change following chemotherapy for AL (light-chain) cardiac amyloidosis.
Br J Haematol
; 177(3): 481-483, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28295184
4.
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
Biol Blood Marrow Transplant
; 17(7): 1051-7, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21073974
5.
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma.
J Clin Oncol
; 37(22): 1946-1955, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31188726
6.
Dysregulated human myeloid nuclear differentiation antigen expression in myelodysplastic syndromes: evidence for a role in apoptosis.
Cancer Res
; 66(9): 4645-51, 2006 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16651415
7.
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma.
Bone Marrow Transplant
; 53(6): 701-707, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29703965
8.
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes.
Leuk Lymphoma
; 48(9): 1728-35, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17786708
9.
Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant.
J Hematol
; 10(1): 35-39, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33643509
10.
Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.
Leuk Lymphoma
; 44(2): 241-9, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12688340
11.
Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.
Bone Marrow Transplant
; 53(6): 795-799, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29540851
12.
Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy.
Bone Marrow Transplant
; 53(12): 1589-1592, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29915217
Resultados
1 -
12
de 12
1
Próxima >
>>